BioMarin Pharmaceutical | BMRN - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2026 0.23 1.49 0.12 Nov/02
FY2026Q2 Jun/2026 1.20 0.95 1.44 Aug/06
FY2026Q1 Mar/2026 0.76 0.74 1.13 May/04
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27




Eps Alterar Data
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agios Pharmaceuticals USD -1.09 0.6 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Amgen USD 6.45 0.16 2026-09
Bayer EUR 0.31 0.64 2026-09
Biogen USD 2.62 0.98 2026-09
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Gilead Sciences USD 2.55 9.3 2026-09
Incyte USD -3.6 6.69 2026-09
Insmed USD -0.46 0.4 2026-09
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Moderna USD 0.38 2.35 2026-09
Neurocrine Biosciences USD 3.29 0.44 2026-09
PTC Therapeutics USD -0.62 1.54 2026-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 0.14 2.02 2026-06
Sarepta Therapeutics USD 0.13 0.51 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
United Therapeutics USD 5.71 1.56 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09